Zobrazeno 1 - 10
of 120
pro vyhledávání: '"J-P. Degaute"'
Autor:
J P, Degaute, J P, Cornil
Publikováno v:
Acta clinica Belgica. 30(1)
One of the essential requisites of the treatment of catabolism inducing diseases is the maintenance of an adequate nutritional status. When this cannot be achieved by the usual means (normal or forcible feeding), it is necessary to have recourse to p
Autor:
L. Hansson, H. Lithell, I. Skoog, C. M. Bánki, M. Breteler, A. Castaigne, M. Correia, J-P. Degaute, D. Elmfeldt, K. Engedal, C. Farsang, J. Ferro, V. Hachinski, A. Hofman, O. F. W. James, E. Krisin, M. Leeman, P. W. de Leeuw, D. Leys, A. Lobo, G. Nordby, B. Olofsson, G. Opolski, M. Prince, F. M. Reischies, J. B. Rosenfeld, L. Ruilope, J. Salerno, J. Tilvis R, P. Trenkwalder, A. Zanchetti
Publikováno v:
Blood Pressure. 9:146-151
The Study on COgnition and Prognosis in the Elderly (SCOPE) is a multi-centre, prospective, randomized, double-blind, parallel-group study. The primary objective of SCOPE is to assess the effect of...
Publikováno v:
European Journal of Clinical Pharmacology. 47:477-481
To study patient compliance in hypertensive outpatients amlodipine (5 mg once daily) and slow release nifedipine (20 mg twice daily) were compared in an open, crossover study in general practices. Four methods of assessment for patient compliance (pi
Publikováno v:
Journal of International Medical Research. 22:278-286
Patient compliance with therapy is often poor and overestimated by the treating physician; it is particularly important in cardiovascular diseases such as hypertension and angina pectoris. Compliance was studied in an open parallel study in out-patie
Autor:
W, Ngatchou, D, Lemogoum, A P, Ménanga, A, Nana, A, Olinga, Y, Boukaert, L, Perrin, S, Kouzam, N, Preumont, A, Ramadam, J, Berre, J P, Degaute, J L, Jansens, E, Cogan, M, Gelin, P, Ayele, C, Kouam, R, Essono, R, Ntchoya, B, Ngo Nonga, M, Fokou, M, Toukam, E, Yonta, J, Ndjebet, C, Ambassa, Y, Monkam, P, Ndobo, J, Simo Moyo, A, Njolo, C, Nouedoui, A G, Njuimo, F, Binam, K, Ngu Blackett, J J, Pagbe, S, Kingue, E C, Ndam, W, Muna, J F, Nguimbous, D, De Cannière
Publikováno v:
Revue medicale de Bruxelles. 32(1)
In the framework of implementation of his national program for control and prevention of cardiovascular diseases, Cameroonian government has set up a cardiac surgery project. We report in this manuscript results of one year follow up of the patients
Autor:
P. De Keyser, K. J. Westelinck, L. Bara, R. Six, J. P. Degaute, Georges Rorive, L. Hermans, P. Lanssiers, Marc G. Bogaert
Publikováno v:
Journal of Cardiovascular Pharmacology. 19:38-45
The tolerability of isradipine was evaluated in an open trial of patients with mild-to-moderate essential hypertension as treated in general practice. The primary objective was to identify all adverse reactions, especially those that were newly occur
Publikováno v:
Revue medicale de Bruxelles. 23
Cardiology was present since the very beginning of the Erasme hospital. The Department of Cardiology was created in 1979. This department is made of a hospitalization unit (54 beds), a coronary care unit (12 beds) and a large technical unit. Clinical
Autor:
Olivier Dubourg, Markku S. Nieminen, G. De Simone, J-P Degaute, Dieter Magometschnigg, Yuri Karpov, J-Y Le Heuzey, R. Asmar, Philippe Gosse, P. Amouyel, Roland E. Schmieder, Björn Dahlöf, P. W. De Leeuw, P. Guéret, Lajos Matos, J. Garcia Puig
Publikováno v:
Journal of human hypertension. 16(9)
The PICXEL study is designed to evaluate the effects of long-term administration of very low-dose combination perindopril 2 mg/indapamide 0.625 mg (Per/Ind) vs enalapril in reducing left ventricular hypertrophy (LVH) in hypertensive patients. This mu
Publikováno v:
Revue medicale de Bruxelles. 21(6)
Autor:
E, Ambrosioni, M, Safar, J P, Degaute, P L, Malin, M, MacMahon, D R, Pujol, A, de Cordoüe, D, Guez
Publikováno v:
Journal of hypertension. 16(11)
In accordance with international recommendations on the need to decrease doses of antihypertensive drugs, a low-dose (1.5 mg) sustained-release (SR) formulation of indapamide was developed to optimize the drug's efficacy : safety ratio. The aim of th